• Return to Headlines

Heron Therapeuti Has Returned 27.4% Since SmarTrend Recommendation (HRTX)

By David Diaz

SmarTrend identified an Uptrend for Heron Therapeuti (NASDAQ:HRTX) on October 28th, 2019 at $20.46. In approximately 1 month, Heron Therapeuti has returned 27.44% as of today's recent price of $26.08.

In the past 52 weeks, shares of Heron Therapeuti have traded between a low of $15.68 and a high of $29.49 and are now at $26.08, which is 66% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 0.9% while the 200-day MA has remained constant.

Heron Therapeutics, Inc. operates as a biotechnology company. The Company offers proprietary biochronomer drug delivery technology which is designed to improve the therapeutic profile of injectable pharmaceuticals, as well as focuses on identifying current therapies with the potential to be reformulated.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any shifts in the trajectory of Heron Therapeuti shares.

Log in and add Heron Therapeuti (HRTX) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.

Keywords: spotlights heron therapeuti

Ticker(s): HRTX